SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: BigKNY3 who wrote (5324)8/31/1998 8:35:00 PM
From: BigKNY3  Read Replies (1) | Respond to of 9523
 
Drug Stks Seen As Safe Havens Even As Shrs Get Hammered>WLA
By Melanie Trottman

08/31/98
Dow Jones News Service
(


NEW YORK (Dow Jones)--Large-cap drug stocks - touted as investment havens in a volatile market - are getting hammered Monday. But industry observers aren't shaken.

"I would be loath to panic and sell the drug stocks," said Brown Brothers Harriman & Co. analyst Michael Krensavage. "I still think that they're going to outperform the market."

Not so far today.

The Dow Jones pharmaceutical index has traded off as much as 5.2% Monday and was recently trading down 4.5%, led by Warner-Lambert Co. (WLA), which is off 7.4%, or 5 1/2 points, at 69. Shares of the company traded as low as 67 1/4 in Monday's trading session, off 9.7%.

Schering-Plough Corp. (SGP) has also suffered a big loss, dropping as much as 8.2% Monday. The shares have since pulled back, trading down 4 3/4, or 5%, at 90 1/4.

Even as the sector - which held up well last week - undergoes increased pressure, industry observers maintain the fundamentals of the companies remain strong.

"Drug stocks are still definitely defensive," said Steve Paspal, an analyst with John Hancock Funds subsidiary Sovereign Asset Management.

Market watchers say that's because of their consistency of earnings growth, built-in market demand, high margins and limited overseas exposure



To: BigKNY3 who wrote (5324)9/1/1998 1:10:00 AM
From: HiSpeed  Respond to of 9523
 
Given the present light the market is in, would you agree that it's likely big pharma has little choice but to move with the market; especially if the moves are great? If this is true, is it possible to call a bottom? (I say this because normally I'd jump in PFE at these levels but why fight this tape!)

If this sell off acts like past ones, won't the market tank in the first hour or two of trading Tuesday then start ticking up from there for a ST bounce? Other than that I'm bearish intermediate term and bullish LT. JMO



To: BigKNY3 who wrote (5324)9/1/1998 7:51:00 AM
From: AlienTech  Respond to of 9523
 
WEISS-RATINGS Nearly 60% of HMOs Lost Money in 1997; Weiss Downgrades 133 HMOs, Upgrades 54

Business Editors/Insurance & Health Writers

PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Aug. 31, 1998--U.S. health maintenance organizations suffered a $768 million loss during 1997, with 57% of all companies losing money, according to a study by Weiss Ratings, Inc., the only independent provider of insurance company ratings and analysis.

The study covers 506 HMOs, representing 96% of the nation's HMO members.

"Last year was the third consecutive year of declining profits, but the first year of an actual industrywide loss," commented Martin Weiss, Ph.D., chairman of Weiss Ratings, Inc. "In response, HMOs have been raising rates precisely when consumers are demanding expanded coverage and increased provider choices, catching the industry in a double bind that is likely to intensify."

For every premium dollar received in 1997, HMOs paid out 90.1 cents in medical expenses plus 12.8 cents in administrative expenses on average, wiping out the industry's profits.

These are up from 88.9 cents and 12.5 cents, respectively, in 1996. In order to pay for the excess of expenses over income, many companies were forced to tap capital resources, resulting in a 6.4% decline in capital during the year.

In response, HMOs, which traditionally have had little or no investment risk, have begun building their portfolios of common stock. Although common stock remains a small portion of total assets
-- 2.3% in 1997 -- total common stock holdings increased 105%, from $394.9 million in 1996 to $811.2 million in 1997.

"Following the lead of other health insurers, some HMOs are attempting to replace lost revenues from operations with hoped-for capital gains in the stock market. In view of today's stock market volatility, this could be a high-risk and ill-advised tactic," commented Dr. Weiss.

Weiss ratings are based on an analysis of a company's capital, five-year historical profitability, liquidity, and stability. The latter category combines a series of factors including asset growth, premium growth, strength of affiliate companies, and risk diversification.

Among the 187 HMOs that received a changed rating, 133 were downgraded while 54 were upgraded, based on the analysis of year-end 1997 data.

Notable downgrades include:

-- Kaiser Foundation Health Plan, Inc. (Oakland, CA) A- to B+
-- Oxford Health Plans (NY), Inc. (Norwalk, CT) C- to D+
-- Prudential Health Care Plan, Inc. (Houston, TX) B- to C+

Notable upgrades include:

-- Cigna Healthcare of California, Inc. (Glendale, CA) C+ to B-
-- Harvard Pilgrim Health Care, Inc. (Brookline, MA) D+ to C-
-- Southeastern Group, Inc. (Louisville, KY) C+ to B-

Weiss Ratings issues safety ratings on over 16,000 financial institutions. It is the only major rating agency that receives no compensation from the companies it rates.
For more information, consumers may call 1-800-289-9222 or visit the Weiss Ratings web site at www.weissratings.com.

10 Strongest HMOs in the U.S.

Company State Weiss Safety Rating
-------- ------ -------------------

Blue Shield of California CA A-
Fallon Community Health Plan MA A-
Health Alliance Plan of Michigan MI B+
Kaiser Foundation Health Plan, Inc. CA B+
Kaiser Foundation Health Plan Colorado CO B+
Kaiser Foundation Health Plan
Mid-Atlantic States MD B+
Partners National Health Plans of NC NC A-
Total Health Care, Inc. MI A
Total Health Care Plan, Inc. OH A-
United HealthCare of the Midwest, Inc. MO B+

10 Weakest HMOs in the U.S.

Company State Weiss Safety Rating
-------- ----- -------------------

Beacon Health Plans, Inc. FL E-
Certus HealthCare LLC TX E-
CHA HMO, Inc. KY E
DayMed Health Maintenance Plan, Inc. OH E-
Emerald HMO, Inc. OH E-
Horizon Health Plan, Inc. KS E-
Integrity Health Plan of Mississippi MS E-
North Medical Community Health Plan NY E-
Physicians Health Services of NJ, Inc. NJ E
PriorityPlus of California, Inc. CA E-

A = excellent; B = good; E = very weak; + sign indicates higher
end of scale; - sign indicates lower end

National and state-specific listings of strongest and weakest
HMOs available.

--30--CL/ph*

CONTACT: Ellen Yui, 301/270-8571
Elizabeth Kelley Grace, 561/989-9855

KEYWORD: FLORIDA
INDUSTRY KEYWORD: BANKING INSURANCE MEDICINE